Clinical and Laboratory Haematology 1991: Vol 13 Index

9 Pages·1991·1.3 MB·English

Clin. lab. Haemat. 1991, 13, 405-409
Author index to Volume 13
ABELA M., see VAN RHEE, F. CHIN-YEE I., KEENEY M. & LOHMANN R.C.
ADAMSON D.J.A. & CurRRIE J.M. Reversible Flow cytometric reticulocyte analysis
infertility and Castleman’s disease 349 using thiazole orange; clinical experience
AKHTAR N., THOMPSON J., DURRANT S.T.S., and technical limitations 177
ANGEL C.A., LAUDER I. & Woop J.K. The Cuu Y.C., see WonG K.F.
clinical relevance of plasma viscosity in CINKOTAI K.I., see MACHETA A.T.
Hodgkin’s disease 1 CoLuins P.W., Jones ©. Pocock C. &
ALLEN D.L., see MAYNE K.M. NEWLANDS’ A.C. Microangiopathic
AMATO D., see LISHNER M. haemolysis associated with occult
ANGEL C.A., see AKHTAR N. carcinoma 245
ANTIPASS S.-E.P., see DIMITRIOU P.A. Cook J.D., see Worwoor M.
AOKI S., see TAKAHASHI M. Cooper E.H., see SMITH G.M.
Cooper J., see SMITH G.M.
BAGLIN T.P., CROCKER J., Timmins A., CosTELLO C., Mir N., HUGHES R.A. & RILEY
CHANDLER S. & BOUGHTON B.J. Bone B. Correspondence: Methotrexate-
marrow hypervascularity in patients with induced bone-marrow suppression 322
myelofibrosis identified by infra-red CROCKER J., see BAGLIN T.P.
thermography 341 CuL.is J.O. & Hype R.D. Case report: Acute
BAGLIN T.P., see LEE K. epiglottitis in immunocompromised
BAIN B.J., see BENJAMIN S. patients—-a report of two cases 379
BAKER M..A., see LISHNER M. CUMBER P.M.., see YATES, P.
BARDEN G., see WICKRAMASINGHE S.N. CurRIE J.M., see ADAMSON D.J.A.
BARRETT A.J., see MCMULLIN M.F. Curtis J.E., see SHERIDAN B.L.
BELLINGHAM A.J., see HENDERSON S.J.
BENJAMIN S., BAIN B.J. & DopsworTtH H. D’ONoFRIO G., SALVATI A.M., BERTI P.,
Case report: severe bleeding associated CAPPABIANCA M.P., Marsiti” G.,
with worsening thrombocytopenia follow- QUARANTELLI M., Zin1 G., Casini C., DE
ing alpha interferon therapy for auto- PHILIPPIS C., MANGO G. & FERRINI P.R.
immune thrombocytopenic purpura 315 Analysis of leucocyte populations with the
BERTI P., see D’ONOFRIO G. Coulter S-Plus STKR as a screening tool
BOWELL P.J., see MAYNE K.M. for haematological abnormalities 51
BOUGHTON B.J., see BAGLIN T.P. DALE B.M., see SHEPHERD i.M.
BRADLEY T., see SMITH G.M. DamMILANO I., see CESANA B.M.
BROZOVIC B., see SMITH O.P. DaMILANO I., see, CESANA, B.M.
DAVENPORT P., see ROATH, S.
CAPPABIANCA M.P., see D’ONOFRIO G. Dawe A., see MAJER R.V.
CASSINI C., see D’ONOFRIO G. DE NorONHA R., TAYLOR B.A., WILD G.,
CAVE R.J., see PATTON W.N. TriGER D.R. & Greaves M. Inter-
CESANA B.M., Maroto A.T., GipiuLi L., relationship between platelet count, plate-
DAMILANO I., MASSARO P., POLLI E.E., let IgG, serum IgG, immune complexes
GipiuL! R. & DamILano I. Relevance of and severity of liver disease 127
red cell distribution width (RDW) in the DE PHILIPPIS C., see D’ONOFRIO G.
differential diagnosis of mycrocytic DEPASQUALE A.K., see DIMITRIOU P.A.
anaemias 141 D1 CATALDO A., see SAMPERI P.
CHALVARDIIAN P., see LISHNER M. DIBENEDETTO S.P., see SAMPERI P.
CHAN J.K.C., see WONG K.F. Dimitriou P.A., GERMENIS A.E., KASFIKI
CHANDLER S., see BAGLIN T.P. A.G., DEPASQUALE A.K., KARPATHIOS
CHAPMAN C., see KENDALL R.G. T.E. & Antipas S.-E.P. The effect of
CHARLES P., see SHEPHERD K.M. blood transfusion on *'Cr-red blood cells
405
406 Author index to Volume 13
surface-counting data in homozygous HENDERSON S.J., FISHLOCK K., HorN M.E.C.,
B-thalassaemia 363 Ont L. & BELLINGHAM A.J. Neonatal
DopsworTH H., see BENJAMIN S. screening for haemoglobin variants using
Dupe I.D., see LISHNER M. filter paper-dried blood specimens 327
DUDGEON J., see MURPHY J.A. HiGGs G., see THAME M.
DurRRANT S.T.S., see AKHTAR M. HOFFBRAND A.V., see SMITH O.P.
Hoaa R.B., see MurPHY J.A.
FERNANDES B., see LISHNER M. Horn M.E.C. see HENDERSON S.J.
FERRINI P.R., see D’ONOFRIO, G. HUGHES R.A., see COSTELLO C.
FIDA S., see WICKRAMASINGHE S.N. HuHN D., see OERTEL J.
FISHLOCK K. see HENDERSON S.J. Hulssen C.H. & Kupers E.W. Quick cyto-
FITZSIMONS E.J., see MORRISON M. chemical staining of blood and marrow
Fiowers C.H., see WoRwoop M. cells in a microwave oven 197
Forses M.A., see SMITH G.M. Hunt A.J.A., see SHERIDAN B.L.
FusIWARA M., see TAKAHASHI M. Hype R.D., see CuLLis J.O.
FuNG K.P. see HAN P.
FUTTER J., see SHEPHERD K.M. JONES L., see COLLINS P.W.
GARDNER B., see WICKRAMASINGHE S.N. JONES-LECOINTE A. & GREEN A. Corres-
Garvey B., see Lewis S.M. pondence: Refractory idiopathic throm-
GEARY C.G., see MACHETA A.T. bocytopenia purpura responsive to «
GERMENIS A.E., see DIMITRIOU P.A. interferon 320
JONES-LECOINTE A., see MAJER R.V.
GERRITS W.B.J., see SCHONEWILLE H.
GIDIULI I., see CESANA B.M. JONES-LECOINTE A., GREEN P.J. & LeE H.A.
GIDIULI R., see CESANA B.M. Sub-optimal doses of human recombinant
GoossENs W., VAN DUPPEN V. & VERWILGHEN erythropoietin markedly lower serum
R.L. K,- or K,-EDTA: the anticoagulant ferritin 251
of choice in routine haematology? 291
GRANDISON Y., see THAME M. Kario K., Matsuo, T., NAKAO, K.,
GREAVES M. see DE NORONHA R. YAMAGUCHI N. & #£Martsuo_ T.
GREEN P. Correspondence: Guidelines for Correspondence: The correlation between
implementation of a maximum surgical red cell distribution width and the serum
erythropoietin titres 222
blood order schedule 323
GREEN P.J., see JONES-LECOINTE A. KARPATHIOS T.E., & DimitTRiou P.A.
GREEN P.J., see MAJER R.V. KASFIKI A.G., see DIMITRIOU P.A.
GREEN A. see JONES-LECOINTE A. KEENEY M., see CHIN-YEE I.
GreccG A., see SHEPHERD K.M. KENDALL R.G., CHAPMAN C., HARTLEY A.E.
& Norro_k D.R. Storage and prepara-
HAAK H.L. see SCHONEWILLE H. tion of samples for erythropoietin
HAIN R. see MCMULLIN M.F. radioimmunoassay 189
HAMBLING M.H., see SMITH G.M. KERKHOFS H., see SCHONEWILLE H.
HAN P. & Func K.P. Discriminant analysis of KHOKHAR A.A., see NEILSON R.F.
iron deficiency anaemia and heterozygous KOIKE T., see TAKAHASHI M.
thalassaemia traits: a 3-dimensional selec- KOTASEK D., see SHEPHERD K.M.
tion of red cell indices 351 Koyama §S., see TAKAHASHI M.
HARNETT A.N. see Murpnuy J.A. KUUPERS E.W., see HUISSEN C.H.
Harris R.I., see PATTON W.N. KYLE B., see McKay P.J.
HARRISON B.J., see YATES P.
HARTLEY A.E., see KENDALL R.G. LAUDER I., see AKHTAR N.
HAZLEHURST G., see SMITH O.P. LEE H.A., see JONES-LECOINTE A.
HEARD S.E., Westwoop N.B. & PEARSON T.C. Lee K., BAGLIN T.P. & Marcus R.E. Case
Correspondence: Homozygous haemo- report: Therapy-related leukaemia in
globin O-Arab in pregnancy 319 Wegener’s granulomatosis 207
HEATH A., see WoRWooD M. Lewis M.J., see NARAYANAN M.N.
Author index to Volume 13 407
Lewis S.M., GARVEY B., MANNING R., SHARP of Fanconi’s anaemia in a phenotypically
S.A. & Warpte, J. Lauryl sulphate normal child 387
haemoglobin: a non-hazardous substitute McVerry B.A., see SMITH G.M.
for HiCN in haemoglobinometry 279 MEHTA A.B., see SMITH O.P.
LIEBERMAN B.A., see SHWE K.H. Mir N., see COSTELLO C.
Lipski S., see OERTEL J. MoriyaAMA Y., see TAKASHAI M.
LISsHNER M., AMATO D., CHALVARDJIAN P., Morris J., see THAME M.
BAKER M.A., FERNANDES B., PANTALONY Morrison M. & Fitzsimons E.J. Corres-
D. & Duse I.D. Case report: Unusual pondence: Discrepant INR values strike
findings in two patients with acquired again 221
deletions of the long arm of chromosome Murphy J.A., Pitts J.F., DUDGEON J., HoGG
5 (5q—) 87 R.B. & Harnett A.N. Case report:
Liu YIN J.A., see MACHETA A.T. Retinal detachments due to chronic lym-
LoBECK H., see OERTEL J. phocytic leukaemia 217
LOHMANN R.C., see CHIN-YEE I.
Love E.M., see MACHETA A.T. NAGAYAMA P., see TAKAHASHI M.
Love E.M., see SHWE K.H. NAKAMORI Y., see TAKAHASHI M.
LuciE N.P., see McKay P.J. NAKAO K., see KARIO K.
NARAYANAN M.N. & Lewis M.J. Case report:
Spontaneous complete remission of acute
MACHETA A.T., CINKOTAI K.I., Love E.M.,
myeloid leukaemia with interstitial dele-
Geary C.G. & Liv Yin J.A. Bone
necrosis complicating chronic myeloid tion of chromosome 5 391
leukaemia 163 NASH J., see NG, K.
NEILSON, R.F. & KHOKHAR A.A.
MAHENDRA P., see MCMULLIN M.F.
Corresponence: Red cell aplasia in mother
MaIoLo A.T., see CESANA B.M.
Maser R.V., Dawe A., WEIR P., and son 224
NEWLAND A.C., see SHWE K.H.
JONES-LECOINTE A. & GREEN P.J. Which
tests are most useful in distinguishing NEWLANDS A.C., see COLLINS P.W.
between reactive thrombocytosis and the No CS., see WONG K.F.
thrombocytosis of myeloproliferative Nc K., NasH J. & Woopcock B.E. Case
report: High grade lymphoma of the cere-
disease? 9
bellum: a rare complication of chronic
MANcuso G.R., see SAMPERI P.
lymphatic leukaemia 93
MANGO G., see D’ONOFRIO G.
NorFo_k D.R., see KENDALL R.G.
MANNING R., see Lewis S.M.
NorMAN J.E., see SHEPHERD K.M.
Marcus R.E., see LEE K.
MARSILI G., see D’ONOFRIO G. O’BrRIEN H.A. & SourRIAL N.A. Case report:
MASON K., see THAME M. Severe megaloblastic anaemia presenting
MASSARO P., see CESANA B.M. as pancytopenia with red cell hypoplasia
Matsuo T., see KARIO K. and elevated serum cobalamin and cobal-
Matsuo T., see KARIO K. amin binding proteins 307
MATSUZAKI M., see SHIMAMOTO Y. OERTEL J., Lipski S., Lopeck H. & HUHN D.
Mayne K.M., ALLEN D.L. & BOoweELL P.J. Detection of light chain restriction in
‘Partial D’ women with anti-D alloimmu- chronic B-lymphoid leukaemia and
nization in pregnancy 239 B-non-Hodgkin’s lymphoma 33
McKay P.J., Kyte B., McLaren A., OHNISHI M., see TAKAHASHI M.
McMILLAN M.A. & LuciE N.P. CDS— T ON! L., see HENDERSON S.J.
lymphocytes in renal transplant
recipients 335 PANTALONY D., see LISHNER M.
McLaren A., see McKay P.J. PATTON W.N., CAveE R.J. & Harris R.I. A
McMILLAN M.A., see McKay P.J. study of changes in red cell volume and
McMUuLLIN M.F., MAHENDRA P., HAIN R. haemoglobin concentration during phle-
& BaRRETT A.J. Case _ report: botomy induced iron deficiency and iron
Myelodysplasia as the initial presentation repletion using the Technicon H1 153
408 Author index to Volume 13
PEARSON T.C., see HEARD S.E. intravenous immunoglobulin in the pre-
PINKERTON P.H., see SHERIDAN B.L. natal management of neonatal alloim-
Pitts J.F., see MURPHY J.A. mune thrombocytopenia 75
Pocock C., see COLLINS P.W. SmitH G.M., Forses M.A., Cooper J.,
Poti E.E., see CESANA B.M. BRADLEY T., HAMBLING M.H., COOPER
POTTER M.N., see YATES P. E.H. & McVerry B.A. Prognostic indi-
PRENTICE H.G., see SMITH O.P. cators for the development of AIDS in
HIV antibody positive haemophiliac
QUARANTELLI M., see D’ONOFRIO G. patients: results of a three-year longi-
RaGusaA R., see SAMPERI P. tudinal study 115
RILEY B., see COSTELLO C. SmiTH O.P., PRENTICE H.G., HAZLEHURST G.,
RoatH S. & Davenport P. Leucocyte BrRozovic B., HOFFBRAND A.V. & MEHTA
numbers and quality: their effect on A.B. Blood product support in patients
viscosity 255 undergoing chemotherapy and autolo-
RODEGHIERO F., see TOSETTO A. gous or allogeneic bone marrow trans-
plantation for haematological malig-
SAGE R.E., see SHEPHERD K.M. nancies 107
SALVATI A.M., see D’'ONOFRIO G. Soco N., see TAKAHASHI M.
SAMPERI P., MANCUSO G.R., DIBENEDETTO SOUVIAL N.A., see O'BRIEN H.A.
S.P., Dit CaTaLpo A., RaGusa R. &
SCHILIRO G. High performance liquid TAKAHASHI M., KOIKE T., NAGAYAMA R.,
chromotography (HPLC): a_ simple FustwaRA M., Koyama §S., OHNISHI M..,
method to quantify Hb C, O-Arab, NAKAMoRI Y., SOGA N., Aoki S&.,
Agenogi and F 169 TATEWAKI W., WADA K., MORIYAMA Y. &
SANDERSON §S., see YATES P. SHIBATA A. Myelodysplastic syndrome
SCHILIRO G., see SAMPERI P. with myelofibrosis: myelodysplastic syn-
SCHONEWILLE H., Haak H.L., KerKHors H. & drome as a major primary disorder for
GerRRITS W.B.J. The effect of anti- acute myelofibrosis 17
coagulants on the size of platelets in blood TATEWAKI W., see TAKAHASHI M.
smears in the course of time 67 TAYLOR B.A., see DE NORONHA R.
SERJEANT B., see THAME M. TEPPERMAN A.D., see SHERIDAN B.L.
SERJEANT G., see THAME M. THAME M., GRANDISON Y., Mason K..,
SHarP S.A., see Lewis S.M. THOMPSON M., Hiccs G., Morris J.,
SHEPHERD K.M., CHARLES P., SAGE R.E., SERJEANT B. & SERJEANT G. The red cell
DALE B.M., NorMAN J.E., Korasek D., distribution width in sickle cell disease—is
GreGcG A. & Futter J. Mobilization of it of clinical value? 299
haemopoietic stem cells by cyclophos- THOMPSON J., see AKHTAR N.
phamide into the peripheral blood of THOMPSON M., see THAME M.
patients with haematological malig- THORPE S.J., see WoRWooD M.
nancies 25 TIMMINS A., see BAGLIN T.P.
SHERIDAN B.L., PINKERTON P.H., Curtis J.E., Tosetto A. & RODEGHIERO F. Parallel line
TEPPERMAN A.D. & Hunt A.J.A. Case bioassay in a coagulation laboratory. A
report: The myelokathexis-variant of the program for personal computer use and
myelodysplastic syndrome—a _ second an example application to Ristocetin
example 81 Cofactor assay 371
SHIBATA A., see TAKAHASHI M. TRIGER D.R., see DE NORONHA R.
SHIMAMOTO Y., MATSUZAKI M. & YAMAGUCHI
M. Case report: Effective treatment of the VAN DuPPEN V., see GOOSSENS W.
anaemia associated with multiple VAN RHEE F. & ABELA M. Correspondence:
myeloma by recombinant human Coombs negative haemolytic anaemia res-
erythropoietin 311 ponding to intravenous immunoglobulins
SHWE K.H., Love, E.M., LIEBERMAN B.A. & in a patient with myelodysplastic
NEWLAND A.C. Case report: High dose syndrome 99
Author index to Volume 13 409
VERWILGHEN R.L., see GOOSSENS W. WoncG K.F., CHAN J.K.C., NG C.S. & Cuu
WabDA K., see TAKAHASHI M. Y.C. Case report: Erythroleukaemia-
WARDLE J., see Lewis S.M. associated haemophagocytic syndrome
Waters A.H. Correspondence: Guidelines for 383
implementation of a maximum surgical Woop J.K., see AKHTAR N.
blood order schedule. Reply from Woopcock B.E., see NG K.
Chairman, BCSH 324 Worwoop M., THorPE S.J., HEATH A.,
WEIR P., see MAJER R.V. FLowers C.H. & Cook J.D. Stable lyo-
WeEstTwoop N.B., see HEARD S.E. philized reagents for serum ferritin assay
WICKRAMASINGHE S.N. & _ Fipa _ S&S. 297
Correspondence: Testing the myelotoxic
potential of new anti-HIV drugs in
vitra 397
YAMAGUCHI N., see KARIO K.
WICKRAMASINGHE S.N. Observations on the
YAMAGUCHI M., see SHIMAMOTO Y.
ultrastructure of sinusoids and reticular
YATES P., CUMBER P.M., SANDERSON S. &
cells in human bone marrow 263
HARRISON, B.J. Mesenteric venous throm-
WICKRAMASINGHE §S.N., BARDEN G. &
bosis due to protein C deficiency 137
GARDNER B. Ability of unstimulated and
YaTes P. & PotTreR M.N. Case report:
phorbol-ester-stimulated human _ blood-
Eosinophilic leukaemia with an abnor-
monocyte-derived macrophages to meta-
mality of 5q3l, the site of the IL-5
bolize drugs and its implications 41
gene 211
WILD G., see DE NORONHA R.
WonG K.F. Correspondence: Case report.
Spurious thrombocytosis in a patient with
severe burn 397 ZINI G., see D’ONOFRIO G.

Clin. lab. Haemat. 1991, 13, 411-413
Subject index to Volume 13
Acute leukaemia 255 Disorders, lymphoproliferative 87
Acute myelofibrosis 17 mast-cell 87
AIDS 115 Drug metabolism 41
Alloimmune, neonatal 75
Alloimunization 239 EDTA 291
Alpha-interferon 315 ELISA 297
Anaemia 311 Elevated serum cobalamin 307
Coombs haemolytic 99 binding proteins 307
iron deficiency 141 End stage renal failure 251
Anti-PL“! 75 Eosinophilic leukaemia 211
Anticoagulant 291 Epiglottitis 379
time 67 Erythrocyte survival study 363
Anticoagulants, effect on size of platelets 67 Erythroleukaemia 383
Area distribution width 67 Erythropoietin 311
Autologous bone marrow transplantation 177 recombinant 189
B thalassaemia 141 Fanconi’s anaemia 387
variants 169 Ferritin iron overload 251
Bioassay 371 Fetal, paraumbilical blood sampling 75
Blood count 291 Fibrinogen 9
Blood products 107 Flow cytometry 177
Blood transfusion 363 Fluorescence, mean intensity 177
Blood viscosity 255
Bone marrow necrosis 163 GM-CSF 211
autologous transplantation 177 Granulocyte-macrophage colony-stimulating
staining in microwave oven 197 factor 211
Guthrie card 327
Carcinoma 245
Castleman’s disease 349 Haematological abnormalities 51
Cell numbers 255 malignancies 107
Chemotherapy 107 Haemoglobin A, 169
Children 387 Haemoglobincyanide 279
Choroid 217 Haemoglobinometry 279
Chromatography, high performance liquid 169 Haemoglobinopathy 327
Chromosome 5 (5q—) 87 Haemophagocytic syndrome 383
Chromosomes 391 Haemophilia 115
Chronic leukaemia 255 Haemopoietic stem cells 25
myeloid leukaemia 163 Haemorrhage, in-utero intracranial 75
Clinical sensitivity 51 Hodgkin’s disease 1
Coombs negative haemolytic anaemia 99 Human bone marrow 263
Coulter STKR 51 Human recombinant erythropoietin 251
Cyclophosphamide 25
Cyclosporin 335 IgA 115
Cytochemistry 197 Immunoblastic lymphoma 93
Cytochrome P-540 41 Immunocompromised 379
Immunocytochemistry 33
Differential diagnosis 141 Immunoglobulin, high-dose, prenatal
Diphenylhydantoin 41 management 75
Discriminant analysis 351 Immunoglobulins 99
412 Subject index to Volume 13
In-utero intracranial haemorrhage 75 Non-Hodgkin’s lymphoma 33
Indices, red cell 153
Infertility 349 Orbital radiotherapy 217
Interleukin-3 (IL-3) 211
Interleukin-5 (IL-5) 211
P24 antigen 115
Iron deficiency 153, 351
Paraumbilical fetal blood sampling 75
anaemia 141
Peripheral blood 25
Iron repletion 153
Phenobarbital 41
Iso-electric focusing 327
Phlebotomy 153
Plasma viscosity 1
Laury! sulphate haemoglobin 279 Platelet IgG 127
Leucocyte differential count 51 Platelet area, mean 67
Leukaemia 391 Prognosis, Hodgkin’s disease 1
chronic lymphatic 93 Protein C defiency 137
chronic lymphocytic 217
chronic lymphoid 33
RDW 141, 229
chronic myeloid 163
Radioimmunoassay 189
eosinophilic 211
Reactive thrombosis 9
megakaryoblastic 17
Recombinant erythropoietin 189
Liquid chromatography, high performance 169
Red cell distribution width 141
Liver disease 127
Red cell hypoplasia 307
Lymphatic leukaemia, chronic 93
Red cell indices 153
Lymphocyte subsets 335
Reference limits 141
Lymphoma, immunoblastic 93
Remission 391
Lymphoproliferative disorders 87
Renal transplantation 335
Lyophilization 297
Reticular cells 263
Reticulocyte 177
Macrophages 41, 263 Retinal detachment 217
blood-monocyte-derived 41 Rhesus blood group 239
Malignancies, haematological 25, 107 Richter’s syndrome 93
Marrow blood flow 341
Marrow, cells staining, in microwave oven 197 SS disease 229
Mast-cell disorders 87 Sample preparation 189
Mean fluorescence intensity 177 storage 189
Megakaryoblastic leukaemia 17 Screening tool, Coulter STKR 51
Megaloblastic anaemia 307 Serum ferritin 297
Mesenteric vein 137 Sickle 229
Metabolism, drug 41 Sinusoids 263
Microangiopathic haemolysis 245 Software 371
Microglobulin, B2- 115 Staining of blood and bone marrow cells 197
Microwave 197 Stem cells 25
Monoclonal antibody 297 Superoxide anion radicals 41
Monocytes 41 Surface-counting 363
Multiple myeloma 311 Syndrome, 5q— 87
Myelodysplasia 387 Richter’s 93
Myelodysplastic syndrome 17, 81, 99 Syndromes, myelodysplastic 87
Myelofibrosis 17, 341
Myelokathexis 81
Thalassaemia 351, 363
Myeloproliferative disease 9
Therapy-related leukaemia 207
Thermography 341
Neonatal screening 327 Thiazole orange 177
alloimmune 75 Three-part differential count 51
Subject index to Volume 13 413
Thrombocytopenia 315 Ultrastructure 263
neonatal alloimmune 75
Thrombocytopenias 127
Vascularity 341
Thrombocytosis, reactive 9
Thrombosis 137
Trait, B-thalassaemia 141 Wegener’s granulomatosis 207
Transplantation 107 von Willebrand’s factor 371